Valuation: Amoéba

Market Cap 4.55Cr 5.19Cr 4.22Cr 3.88Cr 7.31Cr 500.7Cr 7.42Cr 50Cr 20Cr 245Cr 19Cr 19Cr 846.35Cr P/E 2026 *
-8.8x
P/E 2027 * 66x
Enterprise Value 5.66Cr 6.46Cr 5.26Cr 4.83Cr 9.1Cr 623.49Cr 9.23Cr 63Cr 25Cr 305.08Cr 24Cr 24Cr 1.05TCr EV / Sales 2026 *
11.1x
EV / Sales 2027 * 3.69x
Free-Float
87.09%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 60 14/12/2023
Chief Tech/Sci/R&D Officer - 01/09/2018
Corporate Officer/Principal - 01/03/2022
Director TitleAgeSince
Director/Board Member - 01/06/2014
Chairman 70 14/12/2023
Director/Board Member 70 25/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-11.21% - - 5.19Cr
+2.97%+13.60%-8.39%-21.92% 323.69Cr
-3.42%-14.40%+0.41%-18.23% 203.7Cr
+0.20%-12.69%-27.49%-40.54% 168.59Cr
-3.54%-5.18%-26.63% - 157.57Cr
+5.76%+7.40%+16.78%-4.17% 154.03Cr
+3.96%+9.26%-8.85%-46.59% 135.77Cr
+1.42%-3.50%-19.03%+20.08% 123.23Cr
+1.03%-0.45%-20.34%-35.49% 110.66Cr
+0.70%-16.87%-35.57%+37.39% 89Cr
Average +0.91%-1.85%-14.35%-13.68% 162.91Cr
Weighted average by Cap. +1.03%-0.23%-12.17%-17.38%

Financials

2026 *2027 *
Net sales 51L 58.21L 47.35L 43.51L 81.98L 56Cr 83.19L 5.64Cr 2.21Cr 27Cr 2.18Cr 2.14Cr 95Cr 1.56Cr 1.77Cr 1.44Cr 1.33Cr 2.5Cr 171.25Cr 2.54Cr 17Cr 6.73Cr 84Cr 6.66Cr 6.52Cr 289.47Cr
Net income -52L -59.35L -48.27L -44.36L -83.59L -57Cr -84.82L -5.75Cr -2.25Cr -28Cr -2.23Cr -2.18Cr -97Cr 6L 6L 5L 5L 9L 6.06Cr 9L 60.83L 23.81L 2.96Cr 23.56L 23.06L 10Cr
Net Debt 1.12Cr 1.27Cr 1.04Cr 95.12L 1.79Cr 122.79Cr 1.82Cr 12Cr 4.83Cr 60Cr 4.78Cr 4.67Cr 207.56Cr 1.18Cr 1.35Cr 1.1Cr 1.01Cr 1.9Cr 130.5Cr 1.93Cr 13Cr 5.13Cr 64Cr 5.08Cr 4.97Cr 220.59Cr
Logo Amoéba
Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.
Employees
-